The intravenous infusion BMSCs derived from health rats but not diabetic rats ameliorated the progression of diabetic cardiomyopathy, which was partly attributed to the inhibited SAHH/Nrf2 signals and redox disorder in diabetic BMSCs. Here, AHCY is linked to diabetic cardiomyopathy.